| Authors: |
Kharouf F; Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada.; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Rheumatology Unit, Department of Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Sheane BJ; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Gao S; Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada., Pereira D; Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada., Cook RJ; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada., Gladman DD; Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada.; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Chandran V; Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada. vinod.chandran@uhn.ca.; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada. vinod.chandran@uhn.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. vinod.chandran@uhn.ca.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. vinod.chandran@uhn.ca. |
